Northern Trust Corp Igm Biosciences, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 137,236 shares of IGMS stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

137,236

Previous 136,796 0.32%

Holding current value

$1.14 Million

Previous $1.14 Million 16.55%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$8.68 - $17.36 $3,819 - $7,638	440 Added 0.32%	137,236 $1.32 Million
Q4 2023 Feb 13, 2024	BUY	$3.94 - $8.79 $3,991 - $8,904	1,013 Added 0.75%	136,796 $1.14 Million
Q3 2023 Nov 13, 2023	BUY	$6.66 - $10.64 $99,959 - $159,695	15,009 Added 12.43%	135,783 $1.13 Million
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $17,489 - $27,636	1,974 Added 1.66%	120,774 $1.11 Million
Q1 2023 May 15, 2023	SELL	$13.74 - $25.76 $17,147 - $32,148	-1,248 Reduced 1.04%	118,800 $1.63 Million

Q4 2022 Feb 13, 2023	BUY	$15.45 - $26.02 $98,864 - $166,501	6,399 Added 5.63%	120,048 $2.04 Million
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $46,923 - $82,191	3,043 Added 2.75%	113,649 $2.58 Million
Q2 2022 Aug 12, 2022	BUY	$13.27 - $25.5 $344,144 - $661,317	25,934 Added 30.63%	110,606 $1.99 Million
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $95,657 - $211,915	7,128 Added 9.19%	84,672 $2.26 Million
Q4 2021 Feb 08, 2022	SELL	$27.59 - $66.39 $81,942 - $197,178	-2,970 Reduced 3.69%	77,544 $2.28 Million
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $1.43 Million - $1.97 Million	-21,740 Reduced 21.26%	80,514 $5.3 Million
Q2 2021 Aug 13, 2021	SELL	$57.98 - $96.6 $50,848 - $84,718	-877 Reduced 0.85%	102,254 $8.51 Million
Q1 2021 May 12, 2021	SELL	$71.56 - $121.23 $839,971 - $1.42 Million	-11,738 Reduced 10.22%	103,131 $7.91 Million
Q4 2020 Feb 11, 2021	SELL	$47.41 - $115.03 $240,747 - $584,122	-5,078 Reduced 4.23%	114,869 $10.1 Million
Q3 2020 Nov 16, 2020	SELL	$43.0 - $84.01 $671,015 - $1.31 Million	-15,605 Reduced 11.51%	119,947 $8.85 Million
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $2.34 Million - $3.44 Million	45,692 Added 50.85%	135,552 $9.9 Million
Q1 2020 May 14, 2020	BUY	$31.51 - $73.75 $541,436 - $1.27 Million	17,183 Added 23.64%	89,860 $5.05 Million
Q4 2019 Feb 14, 2020	BUY	$17.25 - $49.51 $1.25 Million - $3.6 Million	72,677 New	72,677 $2.77 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.5M

Call Options Held

11.1K

Put Options Held

5.1K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $241M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Igm Biosciences, Inc. Transaction History